FindTrial
Sign In

Second trimester abortion with previous lower segment scar

A prospective, parallel, single blinded, non-RCT of Extra amniotic saline infusion (EASI) followed by misoprostol versus misoprostol for second trimester termination of pregnancy with scarred uterus.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039442
Enrollment
60
Registered
2022-01-14
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O048- (Induced) termination of pregnancywith other and unspecified complications

Interventions

Intervention1: Mifegest 200mg Extra amniotic saline infusion and /or misoprostol 200/400mg: under all aseptic measures Foley�s catheter (14-18 Fr) will be introduced through cervix to

Sponsors

SDM College of medical sciences and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Previous LSCS 2.13-20weeks gestation 3. Upto 24weeks(25th sept 2021 amendment) 3.Uterine height upto 24weeks

Exclusion criteria

Exclusion criteria: 1. Non scarred uterus 2. Patient not willing to be a part of the study

Design outcomes

Primary

MeasureTime frame
efficacy, induction interval, side effects of the drug, outcome. Timepoint: induction interval till expulsion side effects till 24 hrs of expulsion outcome till expulsion—

Secondary

MeasureTime frame
The mode of the delivery:- ââ?¬Â¢ complete expulsion ââ?¬Â¢ Dilatation and evacuation ââ?¬Â¢ Hysterotomy. Following expulsion till 24hrsTimepoint: Till 24hrs following expulsion—

Countries

India

Contacts

Public ContactMahalakshmi Gaddi

SDM College of medical sciences and hospital

mahagaddi@gmail.com9686991664

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026